🔎 Trials Near Me

Početna › Prekomjerna tjelesna masa › Arizona › Tucson

Kliničke studije za Prekomjerna tjelesna masa u gradu Tucson, AZ

15 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Tucson i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

U tijeku regrutacijaFaza 3
  • Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

U tijeku regrutacijaFaza 3
  • University of Arizona, Tucson
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Tucson Clinical Research Institute, Tucson
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

U tijeku regrutacijaFaza 3
  • Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Site, Tucson
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 3
  • AURORA-1 Clinical Site, Tucson
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • AURORA-2 Clinical Site, Tucson
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Arizona Clinical Trials, Tucson
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Arizona Clinical Trials, Tucson
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Tucson
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

U tijeku regrutacijaFaza 2
  • Pima Heart, Tucson
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07215559

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

U tijeku regrutacijaFaza 3
  • ACCOMPLISH-1 Research Site, Tucson
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361

Studije za Prekomjerna tjelesna masa u drugim gradovima

Ostale studije u gradu Tucson

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.